Biopol Chemicals IPO
Market Sentiment
IPO Details
IPO Reservation
Market Lot Size
Financial Analysis
| Metric | 2024 | 2025 | Dec 2025 |
|---|---|---|---|
| Revenue | 17.43 | 49.15 | 48.97 |
| Expense | 15.72 | 43.35 | 40.89 |
| Profit (PAT) | 2.96 | 4.33 | 6.00 |
| Total Assets | 17.56 | 31.48 | 48.88 |
| Company | EPS | P/E | Market Cap (Cr) |
|---|---|---|---|
| Rossari Biotech Limited | 24.63 | 20.93 | 16 |
| Fineotex Chemical Limited | 9.44 | 2.30 | 19 |
| Indian Emulsifiers Limited | 10.88 | 7.19 | 20 |
Promoters: Mr. Santanu Sarkar And Mr. Vedant Sarkar
| Shareholding | No. of Shares | Holding % |
|---|---|---|
| Promoter Holding Pre Issue | 79,11,000 | 89.88% |
| Promoter Holding Post Issue | 1,08,05,400 | 65.81% |
Strengths & Risks
- Heavily oversubscribed — 22.4x overall (final).
- Strong institutional (QIB) demand — 21.1x.
- Revenue grew 182% in the latest reported year.
- Solid profit margin — 8.8%.
- Strong return on equity — 38%.
No major red flags in the available data.
Auto-generated from live GMP, subscription, valuation and financial data. Informational only — not investment advice. Always read the RHP before applying.
Company Information
Since its incorporation in 2023, Biopal Chemicals has been involved in the manufacturing and distribution of specialty chemicals like silicones, emulsifiers, biochemicals, and polyelectrolytes. Its products include 40 silicone-based products, 5 emulsifier-based products, 15 biochemical products, and 6 polyelectrolyte products. From textiles, home care, agriculture, to industrial chemicals, its products are used in various industries. Its 4 manufacturing facilities are located in Gujarat and West Bengal, which can manufacture up to 18,25,000 litres of products every year. Moreover, the business also provides technical consultancy services to customers. Furthermore, Bipol Chemicals follows a B2B model, catering to institutional clients instead of retail.
| Purpose | Amount (Cr) |
|---|---|
| Acquisition of industrial land | 12.26 |
| Repayment or prepayment, in full or in part, of borrowings availed by the Company from banks, financial institutions and non-banking financial companies | 11.10 |
| General Corporate Purpose | - |
Resources & Documents
Biopol Chemicals Ltd, D-211, 2nd Floor, Block-D,, Sumel Business Park-6 Near Dudheshwar Circle, Dudheshwar Tavdipura, Ahmedabad, Gujarat, 380004
Biopol Chemicals has set a price band of Rs 104–Rs 108 per share for an issue size of Rs 31 crore in the chemicals sector. The stock listed with a 2.78% gain versus its issue price on February 13, 2026.
Since its incorporation in 2023, Biopal Chemicals has been involved in the manufacturing and distribution of specialty chemicals like silicones, emulsifiers, biochemicals, and polyelectrolytes. Its products include 40 silicone-based products, 5 emulsifier-based products, 15 biochemical products, and 6 polyelectrolyte products. The company operates in the chemicals space.
The issue is promoted by Mr. Santanu Sarkar And Mr. Vedant Sarkar with Smart Horizon Capital Advisors Pvt. Ltd. acting as lead manager. Net proceeds will primarily be used towards Acquisition of industrial land (Rs 12 crore) and Repayment or prepayment, in full or in part, of borrowings availed by the Company from banks, financial institutions and… (Rs 11 crore).
Grey market is quoting a premium of +Rs 1 (+0.9% over issue price), down Rs 3 from the previous session. Final subscription data records overall subscription at 22.39x, retail at 20.80x, QIB at 21.05x, NII at 24.62x.
On fundamentals, the company is posting revenue growth of 182.0%, a profit margin of 8.8%, return on equity of 38.1% in its most recent reported period. Listed peers in this segment include Indian Emulsifiers Limited (P/E 7.19x, market cap Rs 20 crore) and Fineotex Chemical Limited (P/E 2.30x, market cap Rs 19 crore) — useful reference points when evaluating the issue's pricing relative to where the broader sector are trading.
Our data-driven engine currently flags this issue as a Neutral stance — the data is mixed and the risk-reward is balanced rather than one-sided. Past performance does not predict future returns — review the price chart and peer comparison below before trading.
Biopol Chemicals IPO GMP — What It Means
The latest grey market premium for Biopol Chemicals IPO is ₹1 (+0.9%). GMP is an unofficial, dealer-quoted figure that hints at expected listing-day demand — it is not a guaranteed listing price. For Biopol Chemicals it should be read alongside the subscription numbers and the company's fundamentals, since grey-market premiums can swing sharply during the bidding window.
See the full Biopol Chemicals GMP history and trend, or learn how grey market premium works and how reliable it is.
Related IPO
No comments yet. Be the first to share your opinion!